2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine and Acute Coronary Syndrome

2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine has been researched along with Acute Coronary Syndrome in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	4 (100.00)	2.80

Authors

Authors	Studies
Barioli, A; Capodanno, D; D'Agosta, G; Demola, P; Masiero, G; Occhipinti, G; Pompei, G; Ruggiero, R	1
Harris, J; Johnson, TW; Lasserson, D; Loke, YK; Mahadevan, K; Mumford, A; Pouwels, K; Pufulete, M; Reeves, BC	1
Duconge, J; Gonzalez, AF; Gonzalez-Sepulveda, L; Hernandez-Suarez, DF; Marin-Maldonado, F; Melin, K; Naik, H; Nunez, HJ; Rivas-Tumanyan, S; Ruaño, G; Scott, SA	1
Costantini, A; Romagnoli, A; Santoleri, F	1

Trials

2 trial(s) available for 2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine and Acute Coronary Syndrome

Article	Year
Real-world bleeding in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) and prescribed different combinations of dual antiplatelet therapy (DAPT) in England: a population-based cohort study emulating a 'targe Open heart, 2022, Volume: 9, Issue:2 Topics: Acute Coronary Syndrome; Adolescent; Aspirin; Clopidogrel; Cohort Studies; Dinucleoside Phosphates; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Retrospective Studies; ST Elevation Myocardial Infarction; Ticagrelor	2022
Implementing a pharmacogenetic-driven algorithm to guide dual antiplatelet therapy (DAPT) in Caribbean Hispanics: protocol for a non-randomised clinical trial. BMJ open, 2020, 08-06, Volume: 10, Issue:8 Topics: Acute Coronary Syndrome; Algorithms; Caribbean Region; Dinucleoside Phosphates; Hispanic or Latino; Humans; Percutaneous Coronary Intervention; Pharmacogenetics; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prospective Studies; Treatment Outcome	2020

Article

Year

Real-world bleeding in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) and prescribed different combinations of dual antiplatelet therapy (DAPT) in England: a population-based cohort study emulating a 'targe

Open heart, 2022, Volume: 9, Issue:2

Topics: Acute Coronary Syndrome; Adolescent; Aspirin; Clopidogrel; Cohort Studies; Dinucleoside Phosphates; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Retrospective Studies; ST Elevation Myocardial Infarction; Ticagrelor

2022

Implementing a pharmacogenetic-driven algorithm to guide dual antiplatelet therapy (DAPT) in Caribbean Hispanics: protocol for a non-randomised clinical trial.

BMJ open, 2020, 08-06, Volume: 10, Issue:8

Topics: Acute Coronary Syndrome; Algorithms; Caribbean Region; Dinucleoside Phosphates; Hispanic or Latino; Humans; Percutaneous Coronary Intervention; Pharmacogenetics; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prospective Studies; Treatment Outcome

2020

Other Studies

2 other study(ies) available for 2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine and Acute Coronary Syndrome

Article	Year
[Dual antiplatelet therapy (DAPT) after acute coronary syndrome: short DAPT versus de-escalation]. Giornale italiano di cardiologia (2006), 2022, Volume: 23, Issue:7 Suppl 2 Topics: Acute Coronary Syndrome; Clopidogrel; Dinucleoside Phosphates; Drug Therapy, Combination; Dual Anti-Platelet Therapy; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Treatment Outcome	2022
Adherence and persistence analysis in patients treated with double antiplatelet therapy (DAPT) at two years in real life. Patient education and counseling, 2021, Volume: 104, Issue:8 Topics: Acute Coronary Syndrome; Clopidogrel; Dinucleoside Phosphates; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Retrospective Studies; Treatment Outcome	2021